Fight over cell rights

Henrietta Lacks’ estate sues company over ‘stolen’ cells

COLLEGE PARK, Md. — The estate of Henrietta Lacks sued Massachusettsbased Thermo Fischer Scientific on Monday, accusing it of selling cells that doctors at Johns Hopkins Hospital took from the Black woman in 1951 without her knowledge or consent.

Tissue taken from the woman’s tumor before she died of cervical cancer became the first human cells to be successfully cloned. Reproduced infinitely ever since, HeLa cells have become a cornerstone of modern medicine, enabling countless scientific and medical innovations, including the development of the polio vaccine, genetic mapping and even COVID-19 vaccines.

Lacks’ cells were harvested and developed long before the advent of consent procedures used in medicine and scientific research today, but lawyers for her family say Thermo Fisher Scientific, headquartered in Waltham, has continued to commercialize the results well after the origins of the HeLa cell line became well known.

“It is outrageous that this company would think that they have intellectual rights property to their grandmother’s cells. Why is it they have intellectual rights to her cells and can benefit billions of dollars when her family, her flesh and blood, her Black children, get nothing?” one of the family’s attorneys, Ben Crump, said Monday at a news conference outside the federal courthouse in Baltimore.

Johns Hopkins said it never sold or profited from the cell lines, but many companies have patented ways of using them. Crump said these distributors have made billions from the genetic material “stolen” from Lacks’ body.

Another family attorney, Christopher Seeger, hinted at related claims against other companies.

Thermo Fisher Scientific “shouldn’t feel too alone

‘Why is it they have intellectual rights to her cells and can benefit billions of dollars when her family, her flesh and blood, her Black children, get nothing?’

ATTORNEY BEN CRUMP

because they’re going to have a lot of company soon,” Seeger said.

The lawsuit asks the court to order Thermo Fisher Scientific to “disgorge the full amount of its net profits obtained by commercializing the HeLa cell line to the Estate of Henrietta Lacks.” It also wants Thermo Fisher Scientific to be permanently enjoined from using HeLa cells without the estate’s permission.

On its website, the company says it generates about $35 billion in annual revenue. A company spokesman reached by telephone didn’t immediately comment on the lawsuit.

HeLa cells were discovered to have unique properties. While most cell samples died shortly after being removed from the body, her cells survived and thrived in laboratories.

This exceptional quality made it possible to cultivate her cells indefinitely — they became known as the first immortalized human cell line — making it possible for scientists anywhere to reproduce studies using identical cells.

AP PHOTOS TAKING A STAND: Attorney Ben Crump, second from left, walks with Ron Lacks, left, Alfred Lacks Carter, third from left, both grandsons of Henrietta Lacks, and other descendants of Lacks, whose cells have been used in medical research without her permission, outside the federal courthouse in Baltimore, Monday. They announced during a news conference that Lacks’ estate is filing a lawsuit against Thermo Fisher Scientific, seen above in Waltham, for using Lacks' cells, known as HeLa cells.